{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-061717","form_type":"8-K","ticker":"BMRN","cik":"0001048477","company_name":"BIOMARIN PHARMACEUTICAL INC","filed_at":"2026-09-14T13:26:20+00:00","discovered_at":"2026-09-14T13:27:03.414009+00:00","generated_at":"2026-09-14T13:27:07.991569+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"BioMarin appoints Robert Plenge to board, expanding to 11 members","bullets":["Board increased from 10 to 11 members; Robert Plenge, M.D., Ph.D. appointed effective September 10, 2026.","Plenge also named to Science and Technology Committee as an independent non-employee director.","Granted RSUs valued at $400,000 under 2017 Equity Incentive Plan, vesting before next annual meeting.","Eligible for standard non-employee director fees and committee retainers per April 21, 2026 proxy statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-061717","json":"https://secwatch.observer/filing/0001628280-26-061717.json","markdown":"https://secwatch.observer/filing/0001628280-26-061717.md","text":"https://secwatch.observer/filing/0001628280-26-061717.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026061717/0001628280-26-061717-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026061717/bmrn-20260910.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T13:27:07.991569+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"43f4391f68","claim":"Robert Plenge, M.D., Ph.D. was appointed as Director at BIOMARIN PHARMACEUTICAL INC.","evidence_excerpt":"appointed Robert Plenge, M.D., Ph.D., to the Board, to be effective September 10, 2026","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026061717/0001628280-26-061717-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}